HENGRUI PHARMA

Forecast & Rating11 analysts currently cover HENGRUI PHARMA, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$77.50, about 54.5% upside from the current price of HK$50.15. Price targets range from HK$55.08 to HK$120.75 — a wide spread, showing clear disagreement over just how much HENGRUI PHARMA can rise. For you, this means most professionals who study HENGRUI PHARMA closely still see room for the stock to rise. Data as of Oct 29, 2026; for reference only and not investment advice.